The World Health Organization (WHO) has issued a strong advisory against the use of antibiotics in COVID-19 patients unless there is clear evidence or suspicion of a bacterial infection. The new recommendations are part of the organization’s updated clinical management guidelines for COVID-19, reflecting the evolving nature of the pandemic and health systems.
“For patients with non-severe COVID-19 and no signs of bacterial infection, we recommend against empirical antibiotic use. Similarly, for severe COVID-19 cases with low suspicion of bacterial co-infection, we suggest avoiding antibiotics,” the WHO stated.
These guidelines are based on the latest meta-analysis of global data, which found no significant benefit from using antibiotics in COVID-19 patients without bacterial infections. More importantly, the misuse of antibiotics is contributing to a growing global threat — antimicrobial resistance.
The WHO noted that COVID-19 management has shifted significantly since 2020. Infection rates and disease severity have declined, largely due to widespread vaccination, increased population immunity, and better treatment protocols. As a result, emergency measures have been lifted, and COVID-19 care has now been integrated into routine healthcare systems.
This changing healthcare landscape prompted the WHO to revise and streamline its COVID-19 guidelines. Outdated recommendations and general medical advice not specific to COVID-19 have been removed to maintain clarity and relevance.
The updated advisory is intended for doctors, nurses, hospital administrators, and allied healthcare workers involved in treating COVID-19 and managing post-COVID conditions. The aim is to promote evidence-based care and reduce unnecessary medication, particularly antibiotics.
While the SARS-CoV-2 virus continues to evolve, WHO emphasized that hospitalizations and deaths have declined sharply. Still, the virus poses a risk due to its changing infectivity and ability to escape immunity.
In conclusion, WHO urges healthcare providers to follow the revised guidance carefully, helping ensure better outcomes for patients and slowing the spread of antimicrobial resistance worldwide.
Also Read: US Sees Rise in Hand, Foot and Mouth Disease
